A lot of assets but no cash

Discussion in 'Investment Strategy' started by Darlinghurst Boy, 14th Jul, 2015.

Join Australia's most dynamic and respected property investment community
  1. willair

    willair Well-Known Member Premium Member

    Joined:
    19th Jun, 2015
    Posts:
    6,795
    Location:
    ....UKI nth nsw ....
    Then I will keep an eye on the market next week,and look out for all the new listings..
     
  2. sanj

    sanj Well-Known Member Premium Member

    Joined:
    18th Jun, 2015
    Posts:
    3,470
    Location:
    Perth
    no need to, http://news.asiaone.com/news/business/pharmaceutical-firm-ix-biopharma-launches-ipo

    i did mention it on SS last year, was one of my goals for 2015


    http://somersoft.com/forums/showthread.php?t=104536&page=4

     
  3. willair

    willair Well-Known Member Premium Member

    Joined:
    19th Jun, 2015
    Posts:
    6,795
    Location:
    ....UKI nth nsw ....
    Thanks for the link,.
    The Singapore branch of CIMB Bank is the issue manager and sponsor, while CIMB Securities (Singapore) is the underwriter and placement agent of the IPO. iX Biopharma's share offering will close at noon on July 20. Trading is expected to start at 9am on July 22 - See more at: http://news.asiaone.com/news/busine...x-biopharma-launches-ipo#sthash.Q2rU7GlY.dpuf..

    Pharmaceutical companies are something I don't invest in ,might be ok but sometimes the companies are better at telling everyone you have a problem before the drug is lic and on the market,rather finding new drugs to cure existing diseases,good luck..
     
  4. sanj

    sanj Well-Known Member Premium Member

    Joined:
    18th Jun, 2015
    Posts:
    3,470
    Location:
    Perth
    this focuses more on a quicker delivery system which is one of the reasons i like it, can be applied to so many different drugs.
     
  5. sanj

    sanj Well-Known Member Premium Member

    Joined:
    18th Jun, 2015
    Posts:
    3,470
    Location:
    Perth
    Last edited: 22nd Jul, 2015
    Bayview likes this.